Sodium glucose cotransporter 2 inhibitors eligibility in patients with heart failure across the spectrum of ejection fraction

21 May 2022 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Luca Monzo

Clinical Investigation Centre Pierre Drouin (CIC-P) INSERM, Vandoeuvre-Les-Nancy (France)

6 More presentations in this session

Presentation thumbnail

Thirst in stable heart failure patients; time to reconsider fluid restriction and diuretics

Doctor G. Linssen (Almelo, NL)

Abstract Slides

Presentation thumbnail

Cognitive funtion is a strong determinant of the impact of self-care behaviour on health-related quality of life in patients with heart failure: insights from the DAMOCLES study.

Ms N. Jose-Bazan (Hospitalet De Llobregat, ES)

Abstract Slides

Presentation thumbnail

Quality of life in patients with heart failure and improved ejection fraction

Mrs B. Gonzalez Fernandez (Barcelona, ES)

Abstract Slides

Presentation thumbnail

The gap in health-related quality of life gap according to self-care behavior can be partially explained by the interplay between self-efficacy and literacy in patients with heart failure.

Ms N. Jose-Bazan (Hospitalet De Llobregat, ES)

Abstract Slides

Presentation thumbnail

Screening fragility in outpatients with heart failure: multimodality assessment vs. the Vulnerable Elderly Survey 13 (VES-13) scale

Doctor T. Roig (Badalona, ES)

Abstract Slides

Access the full session

Session thumbnail

Symptoms, quality of life and frailty in heart failure

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

You may be interested in

Congress Presentation

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Congress Presentation

Hypertension and glucose

Congress Presentation

Cardiovascular risk reduction: should we target pre-diabetes?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources